No. 364-Antenatal Corticosteroid Therapy for Improving Neonatal Outcomes.

No. 364-Antenatal Corticosteroid Therapy for Improving Neonatal Outcomes.
J Obstet Gynaecol Can. 2018 Sep;40(9):1219-1239
Authors: Skoll A, Boutin A, Bujold E, Burrows J, Crane J, Geary M, Jain V, Lacaze-Masmonteil T, Liauw J, Mundle W, Murphy K, Wong S, Joseph KS
Abstract
OBJECTIVE: To assess the benefits and risks of antenatal corticosteroid therapy for women at risk of preterm birth or undergoing pre-labour Caesarean section at term and to make recommendations for improving neonatal and long-term outcomes.
OPTIONS: To administer or withhold antenatal corticosteroid therapy for women at high risk of preterm birth or women undergoing pre-labour Caesarean section at term.
OUTCOMES: Perinatal morbidity, including respiratory distress syndrome, intraventricular hemorrhage, bronchopulmonary dysplasia, infection, hypoglycemia, somatic and brain growth, and neurodevelopment; perinatal mortality; and maternal morbidity, including infection and adrenal suppression.
INTENDED USERS: Maternity care providers including midwives, family physicians, and obstetricians.
TARGET POPULATION: Pregnant women.
EVIDENCE: Medline, PubMed, Embase, and the Cochrane Library were searched from inception to September 2017. Medical Subject Heading (MeSH) terms and key words related to pregnancy, prematurity, corticosteroids, and perinatal and neonatal mortality and morbidity were used. Statements from professional organiza...

Source: Journal of Obstetrics and Gynaecology Canada : JOGC - October 1, 2018 Category: OBGYN Tags: J Obstet Gynaecol Can Source Type: research